Inventor · disambiguated record
Cristiana Guiducci
Also filed as: GUIDUCCI CRISTIANA
14 granted patents·8 pending applications·65 citations·filing 2008–2024
90Inventor score
Files withDYNAVAX TECH CORP9NURIX THERAPEUTICS INC6BARRAT FRANCK3INST NAT SANTE RECH MED1MERCK SHARP & DOHME1
Top patents by PatentIndex Score
22 records- 0195US9993495B2Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lungDYNAVAX TECH CORP·Filed 2016·Granted Jun 12, 2018·9 cites·35 claims
- 0291US9868955B2Human toll-like receptor inhibitors and methods of use thereofDYNAVAX TECH CORP·Filed 2013·Granted Jan 16, 2018·11 cites·20 claims
- 0390US10751412B2Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancerMERCK SHARP & DOHME·Filed 2016·Granted Aug 25, 2020·6 cites·28 claims
- 0490US8940310B2Methods of treatment using TLR7 and/or TLR9 inhibitorsBARRAT FRANCK·Filed 2011·Granted Jan 27, 2015·17 cites·33 claims
- 0587US9228184B2Human toll-like receptor inhibitors and methods of use thereofDYNAVAX TECH CORP·Filed 2013·Granted Jan 5, 2016·10 cites·28 claims
- 0683US12121540B2CBL inhibitors and compositions for use in adoptive cell therapyNURIX THERAPEUTICS INC·Filed 2020·Granted Oct 22, 2024·1 cites·48 claims
- 0783US12016860B2Combination therapies with Cbl-b inhibitor compoundsNURIX THERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·1 cites·4 claims
- 0883US8962579B2Methods and compositions for inhibition of immune responses and autoimmunityBARRAT FRANCK·Filed 2010·Granted Feb 24, 2015·6 cites·36 claims
- 0977US10111899B2Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lungDYNAVAX TECH CORP·Filed 2018·Granted Oct 30, 2018·2 cites·21 claims
- 1071US10369168B2Administration of polynucleotide toll-like receptor 9 agonists for treating cancerDYNAVAX TECH CORP·Filed 2018·Granted Aug 6, 2019·0 cites·23 claims
- 1171US9347064B2Methods of treatment using TLR7 and/or TLR9 inhibitorsDYNAVAX TECH CORP·Filed 2014·Granted May 24, 2016·1 cites·19 claims
- 1269US2025161303A1Combination therapies with cbl-b inhibitor compoundsNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1366US9063123B2Transgenic mice expressing human toll-like receptor 8BARRAT FRANCK·Filed 2012·Granted Jun 23, 2015·1 cites·11 claims
- 1463US11918648B2Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating cancerMERCK SHARP & DOHME LLC·Filed 2020·Granted Mar 5, 2024·0 cites·9 claims
- 1560US2025017922A1Bifunctional compounds for degrading btk with enhanced imid activityNURIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1658US2024336595A1Bifunctional compounds for degrading btk with diminished imid activityNURIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1753US2025009731A1Toll-like receptor therapy combinations with cbl-b inhibitor compoundsNURIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1848US2009131512A1Inhibition of type I in IFN productionINST NAT SANTE RECH MED·Filed 2008·Application pending·0 cites
- 1947US9476053B2Methods and compositions for inhibition of immune responses and autoimmunityDYNAVAX TECH CORP·Filed 2015·Granted Oct 25, 2016·0 cites·37 claims
- 2047US2016003807A1Tlr8 transgenic animalsDYNAVAX TECH CORP·Filed 2015·Application pending·0 cites
- 2138US2018161427A1Combination of an anti-il-10 antibody and a cpg-c type oligonucleotide for treating cancerYU YING·Filed 2016·Application pending·0 cites
- 2237US2017326232A1Intratumoral administration of particles containing a toll-like receptor 9 agonist and a tumor antigen for treating cancerDYNAVAX TECH CORP·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →